In bed all the time with ME/CFS, now somewhat better on low-dose naltrexone
- Condition
- ME/CFS
- At worst
- Severe (mostly bedbound)
- Ill before improving or writing
- Not stated
- Last post
- Apr 2026
In their words
- Condition: ME/CFS
I work hard to avoid or minimize PEM.
In context ↗ - At worst: Severe
I’m still in bad shape, but now I spend all of my time in the living room instead of bed.
In context ↗ - Now: Somewhat better
So I’m not thriving, but my fatigue is a lot more bearable.
In context ↗
Read from 5 of their posts and comments; links to the 4 this page draws on
Summary
A long-COVID patient who spent all their time in bed with extreme sound sensitivity mentioned nattokinase and credited low-dose naltrexone, titrated from 0.5 mg to 4.5 mg over several months. They moved from bed to the living room; hyperacusis and fatigue lessened, with no downside after almost two years. A specialist later raised them to 9 mg. By April 2026 they were still severely limited, at about 1,000 steps a day, though their fatigue was far more bearable.
Ask Miruvor AI
What they tried
What they credit
Also tried
Their words about each treatment
- LDN (low-dose naltrexone) · Helped a lot
It’s been great for me. I’m still in bad shape, but now I spend all of my time in the living room instead of bed.
In context ↗ - nattokinase · Helped
So far, nattokinase.
In context ↗ - drastically reduced activity and stimuli · Helped
I’ve also drastically reduced my activity and stimuli, and I work hard to avoid or minimize PEM.
In context ↗ - Laser Lite ear plugs, Loop Quiet ear plugs, Decibel Defense ear muffs · Helped
These still don’t block all sound, they just reduce it.
In context ↗
Approaches: Anticoagulants · Pacing
Their path
How ill they were on the ME/CFS severity scale, estimated from what they describe at each point, in the order they describe; they don’t give enough times to place each step. Hover or tap a point. Dates are when they posted. What the levels mean.
Show as a table
| When | What happened | Where they were | After |
|---|---|---|---|
| — | in bed all the time, extreme sound sensitivitynow I spend all of my time in the living room instead of bed ... (It was extreme before.)In context ↗ | Severe | |
| 2025-08-29 | out of bed into the living room; hyperacusis and fatigue much reduced on LDNHyperacusis still present, but greatly reduced. (It was extreme before.) Fatigue lessened.In context ↗ | Severe | Low-dose naltrexone |
| 2026-04-17 | still severely limited on 9 mg LDN, minimal activity and stimuli to avoid PEMonly ~1,000 steps per day. So I’m not thriving, but my fatigue is a lot more bearable.In context ↗ | Severe | Low-dose naltrexone |
Symptoms mentioned
Their words about their symptoms
- Light & noise sensitivity
For my sound sensitivity I use Laser Lite (LL) ear plugs most of the time
In context ↗ - Post-exertional malaise
I work hard to avoid or minimize PEM
In context ↗
Ask Miruvor AI
Similar stories
-
Nearly bedbound for a year with long COVID, now much better with pacing and carnivore diet
A Dutch man in his early twenties became nearly bedbound for a year after a fourth COVID infection. Pacing, a carnivore diet, nattokinase, electrolytes, creatine and probiotics brought gradual gains; by 2025 he worked full time and biked again, though…
-
Bedbound at times with long COVID, now nearly back to normal with low-dose naltrexone and pacing
A severe reaction to a Pfizer booster in June 2022 left her with neuro, POTS, gut and suspected mast-cell symptoms, plus crashes that could leave her bedbound. She credits low-dose naltrexone, pacing and gradual daily walking for improving to about 70% by…
-
Long COVID with PEM, daily headache and POTS, now somewhat better with pacing
Hawk 17019 developed long COVID in July 2022 after a COVID infection, with PEM, daily headache, POTS, suspected MCAS, gut and sleep problems. Low-dose naltrexone, ketotifen, antihistamines and a low-histamine diet brought them to 60-80% by spring 2024. A…
-
Mostly in bed with ME/CFS, partial gains from LDN and IV fluids then relapses
Trail 92725, in the UK, dated their decline to the first vaccines in early 2021 and was mostly in bed by 2025, on top of long-standing POTS, MCAS and hEDS. LDN, weekly IV fluids, aciclovir, ketotifen and mestinon brought partial gains, but crashes in October…